|
1
|
World Health Organization: COVID-19
strategic preparedness and response plan: Operational planning
guidelines to support country preparedness and response. Geneva:
World Health Organization, 2020.
|
|
2
|
Zoumpourlis V, Goulielmaki M, Rizos E,
Baliou S and Spandidos DA: The COVID-19 pandemic as a scientific
and social challenge in the 21st century. Mol Med Rep.
22:2035–3048. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jentsch PC, Anand M and Bauch CT:
Prioritising COVID-19 vaccination in changing social and
epidemiological landscapes: A mathematical modelling study. Lancet
Infect Dis. 21:1097–1106. 2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
O'Callaghan C, Cloutman-Green E and
Brierley J: Pandemic preparedness: Is the UK ready for a pandemic
that affects children? BMJ. 383(2804)2023.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Qin Z, Sun Y, Zhang J, Zhou L, Chen Y and
Huang C: Lessons from SARS-CoV-2 and its variants (review). Mol Med
Rep. 26(263)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Quinn GA, Connolly R, ÓhAiseadha C, Hynds
P, Bagus P, Brown RB, Cáceres CF, Craig C, Connolly M, Domingo JL,
et al: What lessons can be learned from the management of the
COVID-19 pandemic? Int J Public Health. 70(1607727)2025.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Markiewicz L, Drazkowska K and Sikorski
PJ: Tricks and threats of RNA viruses-towards understanding the
fate of viral RNA. RNA Biol. 18:669–687. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Singh M, Jayant K, Singh D, Bhutani S,
Poddar NK, Chaudhary AA, Khan SU, Adnan M, Siddiqui AJ, Hassan MI,
et al: Withania somnifera (L.) Dunal (Ashwagandha) for the possible
therapeutics and clinical management of SARS-CoV-2 infection:
Plant-based drug discovery and targeted therapy. Front Cell Infect
Microbiol. 12(933824)2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Sharma H, Ilyas A, Chowdhury A, Poddar NK,
Chaudhary AA, Shilbayeh SAR, Ibrahim AA and Khan S: Does COVID-19
lockdowns have impacted on global dengue burden? A special focus to
India. BMC Public Health. 22(1402)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
No authors listed: Post-COVID-19 Condition
Treatment and Management Rapid Scoping Review: Scoping review.
CADTH Health Technology Review. Canadian Agency for Drugs and
Technologies in Health, Ottawa, ON, 2022.
|
|
11
|
Nishimura M: High-flow nasal cannula
oxygen therapy devices. Respir Care. 64:735–742. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Crimi C, Pierucci P, Renda T, Pisani L and
Carlucci A: High-flow nasal cannula and COVID-19: A clinical
review. Respir Care. 67:227–240. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ischaki E, Pantazopoulos I and Zakynthinos
S: Nasal high flow therapy: A novel treatment rather than a more
expensive oxygen device. Eur Respir Rev. 26(170028)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Roca O, Messika J, Caralt B,
García-de-Acilu M, Sztrymf B, Ricard JD and Masclans JR: Predicting
success of high-flow nasal cannula in pneumonia patients with
hypoxemic respiratory failure: The utility of the ROX index. J Crit
Care. 35:200–205. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
D'Cruz RF, Hart N and Kaltsakas G:
High-flow therapy: Physiological effects and clinical applications.
Breathe (Sheff). 16(200224)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Hernández G, Vaquero C, González P, Subira
C, Frutos-Vivar F, Rialp G, Laborda C, Colinas L, Cuena R and
Fernández R: Effect of postextubation high-flow nasal cannula vs
conventional oxygen therapy on reintubation in low-risk patients: A
randomized clinical trial. JAMA. 315:1354–1361. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hernández G, Vaquero C, Colinas L, Cuena
R, González P, Canabal A, Sanchez S, Rodriguez ML, Villasclaras A
and Fernández R: Effect of postextubation high-flow nasal cannula
vs noninvasive ventilation on reintubation and postextubation
respiratory failure in high-risk patients: A randomized clinical
trial. JAMA. 316:1565–1574. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhu Y, Yin H, Zhang R, Ye X and Wei J:
High-flow nasal cannula oxygen therapy versus conventional oxygen
therapy in patients after planned extubation: A systematic review
and meta-analysis. Crit Care. 23(180)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Granton D, Chaudhuri D, Wang D, Einav S,
Helviz Y, Mauri T, Mancebo J, Frat JP, Jog S, Hernandez G, et al:
High-flow nasal cannula compared with conventional oxygen therapy
or noninvasive ventilation immediately postextubation: A systematic
review and meta-analysis. Crit Care Med. 48:e1129–1136.
2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Douglas N, Ng I, Nazeem F, Lee K, Mezzavia
P, Krieser R, Steinfort D, Irving L and Segal R: A randomised
controlled trial comparing high-flow nasal oxygen with standard
management for conscious sedation during bronchoscopy. Anaesthesia.
73:169–176. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Maitra S, Som A, Bhattacharjee S, Arora MK
and Baidya DK: Comparison of high-flow nasal oxygen therapy with
conventional oxygen therapy and noninvasive ventilation in adult
patients with acute hypoxemic respiratory failure: A meta-analysis
and systematic review. J Crit Care. 35:138–144. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Seow D, Khor YH, Khung SW, Smallwood DM,
Ng Y, Pascoe A and Smallwood N: High-flow nasal oxygen therapy
compared with conventional oxygen therapy in hospitalised patients
with respiratory illness: A systematic review and meta-analysis.
BMJ Open Respir Res. 11(e002342)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kepreotes E, Whitehead B, Attia J,
Oldmeadow C, Collison A, Searles A, Goddard B, Hilton J, Lee M and
Mattes J: High-flow warm humidified oxygen versus standard low-flow
nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): An
open, phase 4, randomised controlled trial. Lancet. 389:930–939.
2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Franklin D, Babl FE, Schlapbach LJ, Oakley
E, Craig S, Neutze J, Furyk J, Fraser JF, Jones M, Whitty JA, et
al: A randomized trial of high-flow oxygen therapy in infants with
bronchiolitis. N Engl J Med. 378:1121–1131. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Kawaguchi A, Yasui Y, deCaen A and Garros
D: The clinical impact of heated humidified high-flow nasal cannula
on pediatric respiratory distress. Pediatr Crit Care Med.
18:112–119. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kwon JW: High-flow nasal cannula oxygen
therapy in children: A clinical review. Clin Exp Pediatr. 63:3–7.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Arruda DG, Kieling GA and Melo-Diaz LL:
Effectiveness of high-flow nasal cannula therapy on clinical
outcomes in adults with COVID-19: A systematic review. Can J Respir
Ther. 59:52–65. 2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li Y, Li C, Chang W and Liu L: High-flow
nasal cannula reduces intubation rate in patients with COVID-19
with acute respiratory failure: A meta-analysis and systematic
review. BMJ Open. 13(e067879)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Pisciotta W, Passannante A, Arina P,
Alotaibi K, Ambler G and Arulkumaran N: High-flow nasal oxygen
versus conventional oxygen therapy and noninvasive ventilation in
COVID-19 respiratory failure: A systematic review and network
meta-analysis of randomised controlled trials. Br J Anaesth.
132:936–944. 2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Oczkowski S, Ergan B, Bos L, Chatwin M,
Ferrer M, Gregoretti C, Heunks L, Frat JP, Longhini F, Nava S, et
al: ERS clinical practice guidelines: High-flow nasal cannula in
acute respiratory failure. Eur Respir J. 59(2101574)2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Loomba RS, Villarreal EG, Farias JS,
Bronicki RA and Flores S: Pediatric intensive care unit admissions
for COVID-19: Insights using state-level data. Int J Pediatr.
2020(9680905)2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wu JH, Wang CC, Lu FL, Huang SC and Wu ET:
The applications of high-flow nasal cannulas in pediatric intensive
care units in Taiwan. J Formos Med Assoc. 124:15–21.
2025.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Albrecht D: Vaccination, politics and
COVID-19 impacts. BMC Public Health. 22(96)2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chung HW, Apio C, Goo T, Heo G, Han K, Kim
T, Kim H, Ko Y, Lee D, Lim J, et al: Effects of government policies
on the spread of COVID-19 worldwide. Sci Rep.
11(20495)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bai W, Sha S, Cheung T, Su Z, Jackson T
and Xiang YT: Optimizing the dynamic zero-COVID policy in China.
Int J Biol Sci. 18:5314–5316. 2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Chen JM and Chen YQ: China can prepare to
end its zero-COVID policy. Nat Med. 28:1104–1105. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
The Lancet Regional Health-Western
Pacific. The end of zero-COVID-19 policy is not the end of COVID-19
for China. Lancet Reg Health West Pac. 30(100702)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Petridou E: Politics and administration in
times of crisis: Explaining the Swedish response to the COVID-19
crisis. Eur Policy Anal. 6:147–158. 2020.
|
|
39
|
Martinez-Valle A: Public health matters:
Why is Latin America struggling in addressing the pandemic? J
Public Health Policy. 42:27–40. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Emanuel EJ, Luna F, Schaefer GO, Tan KC
and Wolff J: Enhancing the WHO's proposed framework for
distributing COVID-19 vaccines among countries. Am J Public Health.
111:371–373. 2021.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yoo KJ, Mehta A, Mak J, Bishai D, Chansa C
and Patenaude B: COVAX and equitable access to COVID-19 vaccines.
Bull World Health Organ. 100:315–328. 2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gonsalves G and Yamey G: Political
interference in public health science during the COVID-19. BMJ.
371(M3878)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fedson DS: COVID-19, host response
treatment, and the need for political leadership. J Publ Health
Policy. 42:6–14. 2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Greer SL, King EJ, Massard da Fonseca E
and Peralta-Santos A (eds): Coronavirus politics: The comparative
politics and policy of COVID-19. University of Michigan Press,
2021.
|
|
45
|
Lazarus JV, Wyka K, White TM, Picchio CA,
Rabin K, Ratzan SC, Parsons Leigh J, Hu J and El-Mohandes A:
Revisiting COVID-19 vaccine hesitancy around the world using data
from 23 countries in 2021. Nat Commun. 13(3801)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lucey CR and Johnston SC: The
transformational effects of COVID-19 on medical education. JAMA.
324:1033–1034. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Frenk J, Chen LC, Chandran L, Groff EOH,
King R, Meleis A and Fineberg HV: Challenges and opportunities for
educating health professionals after the COVID-19 pandemic. Lancet.
400:1539–1556. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Mammas IN, Liston M, Koletsi P, Vitoratou
DI, Koutsaftiki C, Papatheodoropoulou A, Kornarou H, Theodoridou M,
Kramvis A, Drysdale SB and Spandidos DA: Insights in paediatric
virology during the COVID-19 era (review). Med Int (Lond).
2(17)2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mammas IN, Drysdale SB, Charalampous C,
Koletsi P, Papatheodoropoulou A, Koutsaftiki C, Sergentanis T,
Merakou K, Kornarou H, Papaioannou G, et al: Navigating paediatric
virology through the COVID-19 era (Review). Int J Mol Med.
52(83)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fischhoff B and Scheufele DA: The science
of science communication. Introduction. Proc Natl Acad Sci USA. 110
(Suppl 3):S14031–S14032. 2013.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Amer P: Coronavirus conversations: Science
communication during a pandemic. Nature: May 27, 2020 (Epub ahead
of print).
|
|
52
|
Rubin R: When physicians spread
unscientific information about COVID-19. JAMA. 327:904–906.
2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Joseph AM, Fernandez V, Kritzman S, Eaddy
I, Cook OM, Lambros S, Jara Silva CE, Arguelles D, Abraham C,
Dorgham N, et al: COVID-19 Misinformation on social media: A
scoping review. Cureus. 14(e24601)2022.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Lurie P, Adams J, Lynas M, Stockert K,
Carlyle RC, Pisani A and Evanega SD: COVID-19 vaccine
misinformation in English-language news media: Retrospective cohort
study. BMJ Open. 12(e058956)2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wilson SL and Wiysonge C: Social media and
vaccine hesitancy. BMJ Glob Health. 5(e004206)2020.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Schwarzinger M and Luchini S: Addressing
COVID-19 vaccine hesitancy: Is official communication the key?
Lancet Public Health. 6:e353–e354. 2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Karafilakis E, Van Damme P, Hendrickx G
and Larson HJ: COVID-19 in Europe: New challenges for addressing
vaccine hesitancy. Lancet. 399:699–701. 2022.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Heuss SC, Zachlod C and Miller BT:
‘Social’ media? How Swiss hospitals used social media platforms
during the early months of the COVID-19 pandemic crisis. Public
Health. 219:53–60. 2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Rubin EJ, Baden LR and Morrissey S: Audio
interview: Covid-19 takeaways at podcast 100. N Engl J Med.
386(e11)2022.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Boender TS, Louis-Ferdinand N and Duschek
G: Digital visual communication for public health: Design proposal
for a vaccinated emoji. J Med Internet Res.
24(e35786)2022.PubMed/NCBI View
Article : Google Scholar
|
|
61
|
Davies SC, Audi H and Cuddihy M:
Leveraging data and new digital tools to prepare for the next
pandemic. Lancet. 397:1349–1350. 2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Sachs JD, Karim SSA, Aknin L, Allen J,
Brosbøl K, Colombo F, Barron GC, Espinosa MF, Gaspar V, Gaviria A,
et al: The lancet commission on lessons for the future from the
COVID-19 pandemic. Lancet. 400:1244–1280. 2022.PubMed/NCBI View Article : Google Scholar
|
